Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 21, 2007Journal of Clinical OncologyOpen Access

Randomized, Double-Blind, Placebo-Controlled Trial of Erythropoietin in Non–Small-Cell Lung Cancer With Disease-Related Anemia

View Full Paper
Ask AI
Bookmark
Share

Authors

JWJames R. WrightAmerican College of RadiologyYUYee UngSunnybrook Health Science CentreJJJim A. JulianVascular Medicine

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wright et al. (2007) studied this question.

synapsesocial.com/papers/69d8972918b0ca7f91d18554https://doi.org/10.1200/jco.2006.07.1514
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Efficacy and Safety Analysis of Epoetin Alfa in Patients With Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial2005 · 84 citations
  2. 2Fatigue in cancer patients compared with fatigue in the general United States population2002 · 854 citations
  3. 3Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group.1997 · 706 citations
  4. 4Use of Epoetin in Patients With Cancer: Evidence-Based Clinical Practice Guidelines of the American Society of Clinical Oncology and the American Society of Hematology2002 · 418 citations
  5. 5Cancer-Related Fatigue: Prevalence of Proposed Diagnostic Criteria in a United States Sample of Cancer Survivors2001 · 654 citations